論文

査読有り 国際誌
2013年7月

An epigenetic modifier enhances the production of anti-diabetic and anti-inflammatory sesquiterpenoids from Aspergillus sydowii

BIOORGANIC & MEDICINAL CHEMISTRY
  • Yu-Ming Chung
  • Chien-Kei Wei
  • Da-Wei Chuang
  • Mohamed El-Shazly
  • Chi-Ting Hsieh
  • Teigo Asai
  • Yoshiteru Oshima
  • Tusty-Jivan Hsieh
  • Tsong-Long Hwang
  • Yang-Chang Wu
  • Fang-Rong Chang
  • 全て表示

21
13
開始ページ
3866
終了ページ
3872
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1016/j.bmc.2013.04.004
出版者・発行元
PERGAMON-ELSEVIER SCIENCE LTD

The addition of a DNA methyltransferase inhibitor, 5-azacytidine, to Aspergillus sydowii fungus culture broth changed its secondary metabolites profile. Analysis of the culture broth extract led to the isolation of three new bisabolane-type sesquiterpenoids: (7S)-(+)-7-O-methylsydonol (1), (7S,11S)-(+)-12-hydroxysydonic acid (2) and 7-deoxy-7,14-didehydrosydonol (3), along with eight known compounds. The isolated compounds were evaluated for their anti-diabetic and anti-inflammatory activities. Among the isolates, (S)-(+)-sydonol (4) did not only potentiate insulin-stimulated glucose consumption but also prevented lipid accumulation in 3T3-L1 adipocytes. Additionally, (S)-(+)-sydonol (4) exhibited significant anti-inflammatory activity through inhibiting superoxide anion generation and elastase release by fMLP/CB-induced human neutrophils. This is the first report on isolating a secondary metabolite with anti-diabetic and anti-inflammatory activities from microorganisms. (C) 2013 Elsevier Ltd. All rights reserved.

リンク情報
DOI
https://doi.org/10.1016/j.bmc.2013.04.004
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/23647825
Web of Science
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000320347100025&DestApp=WOS_CPL
ID情報
  • DOI : 10.1016/j.bmc.2013.04.004
  • ISSN : 0968-0896
  • eISSN : 1464-3391
  • PubMed ID : 23647825
  • Web of Science ID : WOS:000320347100025

エクスポート
BibTeX RIS